Old Web
English
Sign In
Acemap
>
authorDetail
>
Jianxuan Zou
Jianxuan Zou
University of Texas MD Anderson Cancer Center
Cancer research
Biology
Pomalidomide
Cereblon
Bortezomib
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance.
2020
Journal of Molecular Medicine
Jianxuan Zou
Richard J. Jones
Hua Wang
Isere Kuiatse
Fazal Shirazi
Elisabet E. Manasanch
Hans C. Lee
Robert W. Sullivan
Leah Fung
Normand Richard
Paul Erdman
Eduardo Torres
David Hecht
Imelda Lam
Brooke McElwee
Aparajita Hoskote Chourasia
Kyle W. H. Chan
Frank Mercurio
David I. Stirling
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (1)
Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma.
2020
Proceedings of the National Academy of Sciences of the United States of America
Fazal Shirazi
Richard J. Jones
Ram Kumar Singh
Jianxuan Zou
Isere Kuiatse
Zuzana Berkova
Hua Wang
Hans C. Lee
Samuel Hong
Larry Dick
Nibedita Chattopadhyay
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (11)
La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease
2018
Clinical Immunology
Huimin Meng
Xue Sun
Yanhui Song
Jianxuan Zou
Gangli An
Zeming Jin
Lin Yang
Show All
Source
Cite
Save
Citations (6)
Protein Homeostatic Modulators, a Novel Class of Cereblon-Targeting Small Molecules As Potential Clinical Candidates in Multiple Myeloma
2017
Blood
Jianxuan Zou
Richard J. Jones
Janet E. Mertz
Hua Wang
Isere Kuiatse
Bob Sullivan
Leah Fung
Normand Richard
Paul Erdman
Eduardo Torres
Aparajita Hoskote Chourasia
Kyle W. H. Chan
Frank Mercurio
David I. Stirling
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (0)
1